Therapy reports

The Global Cancer Diagnostics Partnering Terms and Agreements 2014-2020 report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Antibiotics Partnering Terms and Agreements 2010 to 2020 report provides comprehensive understanding and unprecedented access to the antibiotic partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Orphan Diseases Partnering 2010-2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Infectious Vaccines Partnering Terms and Agreements 2014 to 2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectious vaccines partnering deals and agreements entered into by the worlds leading healthcare companies.

Global Musculoskeletal Partnering 2014-2020: Deal trends, players and financials provides comprehensive understanding and unprecedented access to the musculoskeletal partnering deals and agreements entered into by the worlds leading healthcare companies.

Global Metabolic Partnering 2014-2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the metabolic partnering deals and agreements entered into by the worlds leading healthcare companies.

Global Infectious Diseases Partnering 2014-2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectious partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Oncology Partnering 2015-2020: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies

The Global Cancer Vaccine Partnering Terms and Agreements 2010-2020 provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020 report provides comprehensive understanding and unprecedented access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies.